Interactions on record — worth a quick check against your medications. Based on 5 of 6 ingredients. Check your meds →
Dietary supplement

Vein Fruit Punch Ingredients & Drug Interactions

by Image Sports

Vein Fruit Punch label
See full label image
Powder Category: Other Combinations
Most serious interaction: Moderate
Clinical methodology reviewed by · Updated Sep 16, 2026 · Label data from the NIH DSLD
What is this page for?

First and foremost: checking Vein Fruit Punch against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.

Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy

The interaction bottom line Most serious interaction: Moderate

Vein Fruit Punch is a dietary supplement by Image Sports with 6 active ingredients. Its ingredients are commonly taken for memory and cognitive support, nerve pain (neuropathy), energy and fatigue.Based on those ingredients, 1,463 medications have a known interaction with it, the most serious rated moderate. The ingredients most likely to interact are Red Sage, Snakeroot, N-Acetyl-L-Carnitine. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.

Jump to a section

Check Your Meds Against Vein Fruit Punch by Image Sports

Ask about any prescription or over-the-counter medication and we check it for interactions with Vein Fruit Punch by Image Sports — and tell you which ingredient is responsible.

Pharmacist-reviewed data Checks every ingredient Answer in seconds
Prefer a human? Send your question to our licensed pharmacists — free, answered by email within 24 hours.

HelloPharmacist Scorecard of Vein Fruit Punch by Image Sports

Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.

From our pharmacy team — supplement deep dive

Generated from HelloPharmacist’s pharmacist-curated databases and editorial rules · Last generated Jul 11, 2026

What’s inside

Low disclosure
Ingredient Transparency · database check
Low

Most active ingredients don't disclose an individual amount — you can't tell how much of each you're getting.

Why this rating?
  • The label discloses an exact amount for 0 of its 6 active ingredients.
  • “VEIN(TM) PROPRIETARY BLEND” is a proprietary blend — the label gives one combined amount (2,000 mg) without saying how much of each component you get.

Vein Fruit Punch contains 6 active ingredients. N-Acetyl-L-Carnitine (a form of carnitine) may support brain function and nerve health.

Glycerol acts as a hydrating agent and may support athletic performance. Red Sage is included for its potential effects on menopausal symptoms and cognitive function.

Quebracho blanco is a botanical extract. The product also contains a proprietary blend labeled VEIN™, plus African palmyra palm and Snakeroot, whose specific roles we cannot detail from the available information.

Inactive ingredients include maltodextrin, natural and artificial flavors, citric acid, sucralose, silica, acesulfame K, FD&C Red No. 40, and vitamin C.

Does it work?

Moderate evidence
Evidence for Intended Use · database check
By FDA rules, dietary supplements can’t claim to treat, cure, or prevent disease — so labels speak in careful marketing language. We discern each product’s intended use from its name, label claims, and label statements, then grade the clinical evidence for that use. How these ratings are computed
Moderate

Some clinical evidence supports this product's ingredients for its stated purpose, but it isn't conclusive.

Why this rating?
  • The label markets this product for: Professional grade vascular and cutting cream.
  • We looked for evidence on: Aging skin, Athletic performance, Dry skin, Skin firmness, Body contouring, Thermogenic support.
  • The strongest evidence on file: Glycerol is rated "Possibly Effective" for Athletic performance (Natural Medicines).
  • Also on file: Glycerol is rated "Insufficient Reliable Evidence To Rate" for Dry skin.
  • Also on file: Sage is rated "Insufficient Reliable Evidence To Rate" for Athletic performance.

N-Acetyl-L-Carnitine is rated Possibly Effective for age-related cognitive decline, Alzheimer disease, alcohol use disorder, diabetic neuropathy, and depression. Glycerol is rated Likely Effective for constipation and Possibly Effective for athletic performance; it is Likely Ineffective for stroke and Possibly Ineffective for meningitis and prematurity.

Red Sage is Possibly Effective for menopausal symptoms, cognitive function, and high cholesterol (hyperlipidemia), but Possibly Ineffective for postoperative pain. We hold no effectiveness data for Quebracho blanco, African palmyra palm, or Snakeroot.

The evidence, ingredient by ingredient Acetyl-l-carnitine Glycerol Sage Quebracho Blanco Aristolochia

How safe is it?

Well-documented data
Safety Information · database check
Well characterized

Adverse-effect, pregnancy, and general safety data are on file for most of these ingredients.

Why this rating?
  • We hold adverse-effect (side-effect) data for 5 of the 5 matched ingredients.
  • Pregnancy & breastfeeding safety ratings cover 5 of 5.
  • General safety write-ups exist for 5 of 5.
  • Remember: this measures how much safety information exists. Thin data is not the same as being safe.

N-Acetyl-L-Carnitine is generally well tolerated short-term, though long-term safety is not fully established. Common side effects include agitation, dry mouth, headache, insomnia, reduced appetite, and occasionally a fishy odor in urine, breath, or sweat.

Nausea, vomiting, diarrhea, and constipation can occur but are uncommon. Glycerol is well tolerated in normal amounts but large doses may cause stomach upset, bloating, diarrhea, nausea, vomiting, dizziness, and headache.

Red Sage is generally well tolerated as a food or short-term tea; concentrated extracts and essential oils require caution. Possible side effects include abdominal pain, agitation, diarrhea, dizziness, nausea, and vomiting.

Quebracho blanco has limited safety data; some users report salivation, headache, sweating, vertigo, drowsiness, and in large doses nausea and vomiting. During pregnancy, avoid medicinal amounts of Red Sage due to thujone content; avoid Quebracho blanco entirely.

While breastfeeding, avoid N-Acetyl-L-Carnitine and Quebracho blanco; avoid medicinal amounts of Red Sage as it may reduce milk supply. Safety data during pregnancy and breastfeeding is not on file for Glycerol.

Side effects, ingredient by ingredient Acetyl-l-carnitine Glycerol Sage Quebracho Blanco Aristolochia

Meds to double-check

Moderate interaction found
Known Interaction Concern · database check
Moderate identified

The most serious documented interaction for these ingredients is Moderate. Check your medications for a personalized result.

Why this rating?
  • 3 of the 5 matched ingredients can interact with medications — Sage, Aristolochia, Acetyl-l-carnitine.
  • The most serious interaction on file is rated Moderate.
  • Some involve high-stakes drug classes: anticoagulant / antiplatelet drugs; seizure medications; diabetes medications.
  • For scale: 1,464 individual medications appear in the full list. A big number alone doesn't make a product dangerous — what matters is whether YOUR medication is on it, so run yours through the interaction checker on this page.

Before taking this product, check whether you use serotonergic drugs (antidepressants, migraine medications), blood thinners (warfarin, acenocoumarol), thyroid replacement hormones, CNS depressants (sedatives, sleep aids), blood pressure medications, or drugs metabolized by liver enzymes CYP2D6, CYP2C19, CYP2C9, or CYP3A4, or transported by P-glycoprotein. All of these are Moderate severity interactions.

Additionally, check if you take hormone therapy, as Red Sage may interfere. If you're unsure whether your medication falls into any of these categories, run it through the checker below.

Check your own medication Run your meds through the checker above

The bottom line

Scorecard at a glanceFormula with limited ingredient disclosure with some supporting evidence for its stated purpose. Moderate medication interactions have been identified, and safety information is well characterized.

Vein Fruit Punch may appeal to those interested in cognitive and cardiovascular support, but it interacts with a broad range of medications including blood thinners, antidepressants, blood pressure drugs, thyroid hormones, and many others metabolized by your liver. If you take any prescription medication—especially for mood, blood clotting, blood pressure, or thyroid function—check your exact drugs with the tool on this page before starting.

Talk to your pharmacist or doctor if you're pregnant, breastfeeding, or have any questions.

Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI

Assessment coverage: 5 of 6 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Mar 25, 2013.

This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed

At a glance

General information

Key facts about Vein Fruit Punch, straight from the product label.

Brand Image Sports
Barcode (UPC) 859123003227
Net contents 120 g
Market status On market
Date entered into DSLD Mar 25, 2013
DSLD ID 18342
Product type Other Combinations
Supplement form Powder
Dietary claims / uses All Other, Structure/Function
Intended target group(s) Adult (18 - 50 Years)
From the label
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.

Supplement Facts

The label details for Vein Fruit Punch by Image Sports, sourced from the NIH Dietary Supplement Label Database.

Supplement Facts

Daily Value (DV) Target Group(s):
Adults and children 4 or more years of age
Minimum serving Sizes:
4 Gram(s)
Maximum serving Sizes:
4 Gram(s)
Servings per container
30
UPC/BARCODE
859123003227
IngredientAmount% DV
N-Acetyl-L-Carnitine0 NP--
Glycerol0 NP--
Red Sage0 NP--
Quebracho blanco0 NP--
VEIN(TM) PROPRIETARY BLEND2000 mg--
African palmyra palm0 NP--
Snakeroot0 NP--

Other ingredients: Maltodextrin, Natural & Artificial flavors, Citric Acid, Sucralose, Silica, Acesulfame K, FD&C Red No. 40, Vitamin C

Tap any ingredient to jump to its full detail below.

Label statements
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
General Statements

STACKING PROTOCOL

THE FIRST EVER PROFESSIONAL GRADE VASCULAR AND CUTTING CREAM

THE FIRST EVER MUSCLE FULLNESS RESPONSE POWDER

PROFESSIONAL GRADE “PUMP” MATRIX*† HIGH SPEED VASCULAR EFFECTS*† CONCENTRACTED “TINGLE” EFFECTS*†

MUSCLE FULLNESS RESPONSE POWDER*†

FREE PRO THERMOGENIC CUTTING CREAM(TM)

FDA Statement of Identity

DIETARY SUPPLEMENT

Suggested/Recommended/Usage/Directions

Suggested use: Apply PRO THERMOGENIC CUTTING CREAM(TM) to clean, dry skin in the morning or evening. Massage a thin layer of cream into the areas you want to improve such as thighs, waist, hips, buttocks, stomach and upper arms.

RECOMMENDED USAGE VEIN(TM) Pre-Workout {1 scoop} Intra-Workout {1 scoop} Post-Workout {1 scoop} PRO THERMOGENIC CUTTING CREAM(TM) AM - PM ONE APPLICATION

Suggested Use: For best results, mix 1 serving (1 scoop) with 6 ounces of ice cold water or your favorite beverage. Consume 30 minutes prior to your workout, during your workout, and/or after your workout.

Precautions

Do not apply PRO THERMOGENIC CUTTTING CREAM(TM) to any other parts of your body.

KEEP OUT OF REACH OF CHILDREN.

Please read entire label before use.

Warnings: Not intended for use by persons under age 18.

Do not exceed recommended dose.

Get the consent of a licensed physician before using this product, especially if you are taking medication, have a medical condition, you are pregnant, nursing or thinking about becoming pregnant.

KEEP THIS PRODUCT AND ALL SUPPLEMENTS OUT OF THE REACH OF CHILDREN.

Warnings: For topical, external use only. Do not ingest. Wash your hands with soap and water immediately after applying PRO THERMOGENIC CUTTING CREAM(TM). Avoid contact with eyes and mucous membranes. In case of contact with eyes, flush liberally with water. If irritation persists, seek medical attention. Before using PRO THERMOGENIC CUTTING CREAM(TM) for the first time, apply a small, pea size amount to your forearm to test your skin’s reaction.

Storage

Storage Conditions: Keep away from direct sunlight, and store in a cool, dry place, at controlled room temperature of not more than 25(0)C (77(0)F). Do not refrigerate.

General

Rev. 01-001-VEI004 02/12

Seals/Symbols

i

Formula

Ingredients: Aqua (Water), Caprylic/Capric Triglyceride, Stearic Acid, Glycerin, C12-15 Alkyl Ethylhexaonate, Dimethicone, Glyceryl Stearate, PEG-100 Stearate, Cetyl Alcohol, Butylene Glycol, Polysorbate 20, Palmitoyl Oligopeptide, PalmitoylTetrapeptide-7, Polysorbate 80, Medium Chain Triglycerides, Ascorbyl Palmitate, Zanthoxylum piperitum D.C. (fruit) extract, Zingiber officinale (root) extract, Niacin (as Nicotinic Acid, USP), Capsicum annuum (fruit) extract, Carbomer, Potassium Hydroxide, 1,2-Hexanediol, Caprylyl Glycol, Phenoxyethanol, Sorbic Acid, Fragrance.

Is this label outdated? Report a formula or label change and our pharmacy team will review it.

See for yourself

Vein Fruit Punch by Image Sports label

The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.

Vein Fruit Punch label

Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.

View the full label (PDF)
What’s inside

The Ingredients in Vein Fruit Punch by Image Sports

These are the 6 active ingredients this product is made of. Select any to open its full monograph.

Serving size4 Gram(s) Dosage formPowder Servings per container30 Amounts shown are per serving.

Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.

VEIN(TM) PROPRIETARY BLEND

2000 mg per serving

Other (inactive) ingredients: Maltodextrin, Natural & Artificial flavors, Citric Acid, Sucralose, Silica, Acesulfame K, FD&C Red No. 40, Vitamin C. These complete the product’s ingredient list but are not active constituents.

Interaction report

Vein Fruit Punch by Image Sports Drug Interactions

Want to check YOUR meds against Vein Fruit Punch?

Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.

 Go to the checker
1,463Drugs
1,463 Moderate

Ingredients driving the most interactions

Red Sage 1,296
Snakeroot 355
N-Acetyl-L-Carnitine 203

Individual Drug Interactions

The ingredients in Vein Fruit Punch interact with 1,463 drugs. Click any drug to see the details.

3 of the 6 ingredients in Vein Fruit Punch interact with drugs. Each result below shows which ingredient is responsible. Red Sage Snakeroot N-Acetyl-L-Carnitine

Each ingredient & the kinds of drugs it affects

For each ingredient in Vein Fruit Punch with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.

Red Sage14 drug types · 1,296 drugs

Anticholinergic Drugs

Theoretically, sage might decrease the clinical effects of anticholinergic drugs.
In vitro evidence suggests that common sage (Salvia officinalis) and Spanish sage (Salvia lavandulaefolia) can inhibit acetylcholinesterase and might increase acetylcholine levels.

Likelihood Possible Evidence D
Anticonvulsants

Theoretically, sage might interfere with the clinical effects of anticonvulsant drugs.
Some species of sage can cause convulsions when consumed in large quantities.

Likelihood Possible Evidence D
Antidiabetes Drugs

Theoretically, taking sage with antidiabetes drugs might increase the risk of hypoglycemia.
In patients with polycystic ovary syndrome (PCOS) or inadequately controlled type 2 diabetes, common sage (Salvia officinalis) has demonstrated hypoglycemic activity. However, other clinical research in patients with inadequately controlled type 2 diabetes shows that common sage extract does not lower fasting blood glucose levels.

Likelihood Possible Evidence B
Antihypertensive Drugs

Theoretically, sage might increase or decrease the effects of antihypertensive drugs.
Animal research suggests that common sage (Salvia officinalis) can cause prolonged blood pressure reduction. However, clinical research suggests that Spanish sage (Salvia lavandulaefolia) can increase blood pressure in some people with hypertension. Until more is known, use with caution.

Likelihood Possible Evidence D
Benzodiazepines

Theoretically, taking sage might increase the sedative and adverse effects of benzodiazepines.
In vitro evidence suggests that certain components of common sage (Salvia officinalis) can bind to benzodiazepine receptors. This effect has not been reported in humans.

Likelihood Possible Evidence D
Cholinergic Drugs

Theoretically, sage might have additive effects when used with cholinergic drugs.
In vitro evidence suggests that common sage (Salvia officinalis) and Spanish sage (Salvia lavandulaefolia) can inhibit acetylcholinesterase and might increase acetylcholine levels.

Likelihood Possible Evidence D
Cns Depressants

Theoretically, taking sage might increase the sedative and adverse effects of CNS depressants.
Some constituents of sage have CNS depressant activity.

Likelihood Possible Evidence D
Cytochrome P450 2C19 (Cyp2C19) Substrates

Theoretically, sage might increase the levels and clinical effects of drugs metabolized by CYP2C19.
In vitro evidence suggests that aqueous extracts of sage can inhibit CYP2C19. So far, this interaction has not been reported in humans.

Likelihood Possible Evidence D
Cytochrome P450 2C9 (Cyp2C9) Substrates

Theoretically, sage might increase the levels and clinical effects of drugs metabolized by CYP2C9.
In vitro evidence suggests that aqueous extracts of sage can inhibit CYP2C9. So far, this interaction has not been reported in humans.

Likelihood Possible Evidence D
Cytochrome P450 2D6 (Cyp2D6) Substrates

Theoretically, sage might increase the levels and clinical effects of drugs metabolized by CYP2D6.
In vitro evidence suggests that aqueous extracts of sage can inhibit CYP2D6. So far, this interaction has not been reported in humans.

Likelihood Possible Evidence D
Cytochrome P450 2E1 (Cyp2E1) Substrates

Theoretically, sage might decrease the levels and clinical effects of drugs metabolized by CYP2E1.
Animal research suggests that drinking common sage (Salvia officinalis) tea increases the expression of CYP2E1. So far, this interaction has not been reported in humans.

Likelihood Possible Evidence D
Cytochrome P450 3A4 (Cyp3A4) Substrates

Theoretically, sage might increase the levels and clinical effects of drugs metabolized by CYP3A4.
In vitro evidence suggests that aqueous extracts of sage can inhibit CYP3A4. So far, this interaction has not been reported in humans.

Likelihood Possible Evidence D
Estrogens

Theoretically, sage might interfere with hormone therapy.
In vitro evidence suggests that geraniol, a constituent of Spanish sage (Salvia lavandulaefolia), exerts estrogenic activity. The clinical significance of this effect is unclear.

Likelihood Possible Evidence D
P-Glycoprotein Substrates

Theoretically, sage might increase levels of drugs transported by P-glycoprotein.
In vitro research suggests that common sage (Salvia officinalis) can inhibit the multi-drug transporter protein, P-glycoprotein. This effect has not been reported in humans.

Likelihood Possible Evidence D
Red Sage full monograph & interactions

Snakeroot1 drug type · 355 drugs

Nephrotoxic Drugs

Aristolochia is nephrotoxic. There are numerous cases of nephropathy and renal failure associated with aristolochia use. Theoretically, combining aristolochia with potentially nephrotoxic drugs might have additive adverse effects on kidney function. However, this interaction has not yet been reported in humans. Close monitoring of renal function in patients taking aristolochia with nephrotoxic drugs may be warranted.
Some potentially nephrotoxic drugs include cyclosporine (Neoral, Sandimmune); aminoglycosides including amikacin (Amikin), gentamicin (Garamycin, Gentak, others), and tobramycin (Nebcin, others); nonsteroidal anti-inflammatory drugs (NSAIDs) including ibuprofen (Advil, Motrin, Nuprin, others), indomethacin (Indocin), naproxen (Aleve, Anaprox, Naprelan, Naprosyn), piroxicam (Feldene); and numerous others.

Likelihood Possible Evidence D
Snakeroot full monograph & interactions

N-Acetyl-L-Carnitine4 drug types · 203 drugs

Acenocoumarol (Sintrom)

Theoretically, acetyl-L-carnitine might increase the anticoagulant effects of acenocoumarol.
L-carnitine, the parent compound of acetyl-L-carnitine, might enhance the anticoagulant effects of acenocoumarol, an oral anticoagulant that is similar to warfarin, but shorter-acting. There are at least two case reports of INR elevation when L-carnitine was taken with acenocoumarol. In one case, a 33-year-old male with a previously stable INR had an elevated INR of 4.65 after L-carnitine was started and continued for 10 weeks. INR normalized after discontinuation of the L-carnitine-containing product. It is unclear if such an interaction would also occur with acetyl-L-carnitine.

Likelihood Possible Evidence D
Serotonergic Drugs

Theoretically, acetyl-L-carnitine might increase the risk of serotonergic side effects, including serotonin syndrome and cerebral vasoconstrictive disorders, when taken with serotonergic drugs.
Animal research shows that acetyl-L-carnitine can increase levels of serotonin in the brain.

Likelihood Possible Evidence D
Thyroid Hormone

Theoretically, acetyl-L-carnitine might decrease the effectiveness of thyroid hormone replacement.
L-carnitine appears to act as a peripheral thyroid hormone antagonist by inhibiting entry of thyroid hormone into the nucleus of cells. Taking L-carnitine also seems to diminish some of the symptoms of hyperthyroidism. It is unclear if such an interaction would occur with acetyl-L-carnitine.

Likelihood Probable Evidence B
Warfarin (Coumadin)

Theoretically, acetyl-L-carnitine might increase the anticoagulant effects of warfarin.
L-carnitine, the parent compound of acetyl-L-carnitine, might increase the anticoagulant effects of acenocoumarol, a shorter-acting oral anticoagulant similar to warfarin. There is not enough information to know whether this interaction occurs with acetyl-L-carnitine and warfarin.

Likelihood Possible Evidence D
N-Acetyl-L-Carnitine full monograph & interactions
The maker

Brand information

Manufacturer and brand details for Vein Fruit Punch, from the product label.

Image Sports

See all Image Sports products
Name
Image Sports
City
Fort Lauderdale
State
FL
ZipCode
33301
Pharmacist Counseling Corner

Vein Fruit Punch by Image Sports: Common Questions

Does Vein Fruit Punch by Image Sports interact with any medications?
Yes. Based on its ingredients, Vein Fruit Punch has a known interaction with 1,463 medications. Use the checker to see how it interacts with a specific drug.
How can one product interact with so many drugs?
Vein Fruit Punch contains 6 active ingredients, and an interaction can come from any of them. We check every ingredient, combine the results into one list per medication, and show which ingredient and mechanism is responsible.
Where does this information come from?
The product label data comes from the NIH Dietary Supplement Label Database (DSLD); the interaction data is built on the Natural Medicines database and reviewed by HelloPharmacist pharmacists.
Is N-Acetyl-L-Carnitine safe long-term?
Short-term use is generally well tolerated, but long-term safety hasn't been fully established. Talk to your doctor if you're considering long-term use.
What are the most common side effects I might notice?
N-Acetyl-L-Carnitine may cause agitation, dry mouth, headache, insomnia, or reduced appetite. Some people report a fishy odor in urine, breath, or sweat. Red Sage can cause nausea, vomiting, diarrhea, abdominal pain, or dizziness. Glycerol in large amounts may cause bloating, nausea, or diarrhea.
Can I take this while pregnant?
No—avoid medicinal amounts of Red Sage during pregnancy due to its thujone content, and avoid Quebracho blanco entirely. There isn't enough data on N-Acetyl-L-Carnitine and Glycerol during pregnancy, so talk with your doctor before using this product if you're pregnant.
Can I take this while breastfeeding?
Avoid N-Acetyl-L-Carnitine and Quebracho blanco while breastfeeding. Avoid medicinal amounts of Red Sage, as it has traditionally been used to reduce milk supply. Talk to your doctor before starting.
Does Red Sage work for hot flashes?
Red Sage is rated Possibly Effective for menopausal symptoms, which would include hot flashes, but the evidence is not definitive. Your results may vary.
What are the inactive ingredients?
The powder contains maltodextrin, natural and artificial flavors, citric acid, sucralose, silica, acesulfame K, FD&C Red No. 40, and vitamin C as inactive ingredients—these are fillers, binders, and flavorings.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Not sure if Vein Fruit Punch is safe with your meds?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.

Vein Fruit Punch label
Go deeper

The Full Monographs Behind Vein Fruit Punch’s Ingredients

Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.

Herb & supplement monograph

Acetyl-l-carnitine

Interacts with 203 drugs

Acetyl-L-carnitine is a form of the amino acid carnitine that the body uses to help produce energy in cells. It is most studied for nerve pain and memory-related conditions, though the evide...

Read the full Acetyl-l-carnitine monograph → Herb & supplement monograph

Glycerol

Glycerol (glycerin) is a sweet, syrupy compound made naturally in the body and widely used in foods, skin products, and medicines. It is well established as a laxative and a skin and eye moi...

Read the full Glycerol monograph → Herb & supplement monograph

Sage

Interacts with 1,296 drugs

Sage is a common kitchen herb that is generally safe in food amounts and is traditionally used for sore throats, digestion, sweating, and memory. Some early research is encouraging for sore...

Read the full Sage monograph → Herb & supplement monograph

Quebracho Blanco

Quebracho Blanco is the bark of a South American tree traditionally used for breathing problems and coughs, but high-quality human studies are lacking. It contains alkaloids that may affect...

Read the full Quebracho Blanco monograph → Herb & supplement monograph

Aristolochia

Interacts with 355 drugs

Aristolochia contains aristolochic acid, a potent toxin linked to severe kidney damage and cancer, and it is not safe to take. The FDA and other health authorities have warned against any pr...

Read the full Aristolochia monograph →
Sources

Sources & How We Checked

Vein Fruit Punch's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.

Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.

The 85 references behind this product’s interaction data

Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.

Acetyl-l-carnitine 22 references
  1. Thal LJ, Carta A, Clarke WR, et al. A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's Disease. Neurology 1996;47:705-11. PubMed
  2. Sano M, Bell K, Cote L, et al. Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's Disease. Arch Neurol 1992;49:1137-41. PubMed
  3. Spagnoli A, Lucca U, Menasce G, et al. Long-term acetyl-L-carnitine treatment in Alzheimer's Disease. Neurology 1991;41:1726-32. PubMed
  4. Brooks JO 3rd, Yesavage JA, Carta A, Bravi D. Acetyl L-carnitine slows decline in younger patients with Alzheimer's disease: a reanalysis of a double-blind, placebo-controlled study using the trilinear approach. Int Psychoger 1998;10:193-203. PubMed
  5. Pettegrew JW, Klunk WE, Panchalingam K, et al. Clinical and neurochemical effects of acetyl-L-carnitine in Alzheimer's disease. Neurobiol Aging 1995;16:1-4. PubMed
  6. Rai G, Wright G, Scott L, et al. Double-blind, placebo controlled study of acetyl-l-carnitine in patients with Alzheimer's dementia. Curr Med Res Opin 1990;11:638-47. PubMed
  7. Benvenga S, Ruggeri RM, Russo A, et al. Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: a randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol Meta
  8. Montgomery SA, Thal LJ, Amrein R. Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. Int Clin Psychopharmacol 2003;18:61-71.. PubMed
  9. Martinez E, Domingo P, Roca-Cusachs A. Potentiation of acenocoumarol action by L-carnitine. J Intern Med 1993;233:94.
  10. Hudson S, Tabet N. Acetyl-L-carnitine for dementia. Cochrane Database Syst Rev 2003;2:CD003158.. PubMed
  11. Bachmann HU, Hoffmann A. Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol. Swiss Med Wkly 2004;134:385. PubMed
  12. De Grandis D, Minardi C. Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study. Drugs R D 2002;3:223-31. PubMed
  13. 12761 Benvenga S, Amato A, Calvani M, Trimarchi F. Effects of carnitine on thyroid hormone action. Ann N Y Acad Sci 2004;1033:158-67. PubMed
  14. Sima AAF, Calvani M, Mehra M, et al. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: An analysis of two randomized, placebo-controlled trials. Diabetes Care 2005;28:89-94.
  15. Youle, M. and Osio, M. A double-blind, parallel-group, placebo-controlled, multicentre study of acetyl L-carnitine in the symptomatic treatment of antiretroviral toxic neuropathy in patients with HIV-1 infection. HIV.Med. 2007;8(4):241-250.
  16. Brennan BP, Jensen JE, Hudson JI, Coit CE, Beaulieu A, Pope HG Jr, Renshaw PF, Cohen BM. A placebo-controlled trial of acetyl-L-carnitine and a-lipoic acid in the treatment of bipolar depression. J Clin Psychopharmacol. 2013 Oct;33(5):627-35.
  17. Ledinek AH, Sajko MC, Rot U. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study. Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S86-9. PubMed
  18. Martinotti G, Andreoli S, Reina D, Di Nicola M, Ortolani I, Tedeschi D, Fanella F, Pozzi G, Iannoni E, D'Iddio S, Prof LJ. Acetyl-l-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. Prog Neuropsychop PubMed
  19. Baek SM, Zheng R, Seo EJ, Hwang DY, Kim BH. Pharmacokinetic comparisons of two acetyl-L-carnitine formulations in healthy Korean volunteers. Int J Clin Pharmacol Ther. 2015;53(11):980-6. PubMed
  20. Goodison G, Overeem K, de Monte V, Siskind D. Mania associated with self-prescribed acetyl-l-carnitine in a man with bipolar I disorder. Australas Psychiatry. 2017;25(1):13-4.
  21. Bruno A, Pandolfo G, Crucitti M, Lorusso S, Zoccali RA, Muscatello MR. Acetyl-L-Carnitine Augmentation of Clozapine in Partial-Responder Schizophrenia: A 12-Week, Open-Label Uncontrolled Preliminary Study. Clin Neuropharmacol. 2016;39(6):277-80. PubMed
  22. Veronese N, Stubbs B, Solmi M, Ajnakina O, Carvalho AF, Maggi S. Acetyl-L-Carnitine Supplementation and the Treatment of Depressive Symptoms: A Systematic Review and Meta-Analysis. Psychosom Med. 2018;80(2):154-9. PubMed

See these in context on the Acetyl-l-carnitine monograph →

Glycerol 8 references
  1. McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.
  2. Wagner DR. Hyperhydrating with glycerol: implications for athletic performance. J Am Diet Assoc 1999;99:207-12. PubMed
  3. Yu YL, Kumana CR, Lauder IJ, et al. Treatment of acute cortical infarct with intravenous glycerol. A double-blind, placebo-controlled randomized trial. Stroke 1993;24:1119-24. PubMed
  4. Frei A, Cottier C, Wunderlich P, Ludin E. Glycerol and dextran combined in the therapy of acute stroke. A placebo-controlled, double-blind trial with a planned interim analysis. Stroke 1987;18:373-9. PubMed
  5. Balaskas E, Szepietowski JC, Bessis D, Ioannides D, Ponticelli C, Ghienne C, Taberly A, Dupuy P. Randomized, double-blind study with glycerol and paraffin in uremic xerosis. Clin J Am Soc Nephrol. 2011 Apr;6(4):748-52. PubMed
  6. Blanchet-Bardon C, Tadini G, Machado Matos M, Delarue A. Association of glycerol and paraffin in the treatment of ichthyosis in children: an international, multicentric, randomized, controlled, double-blind study. J Eur Acad Dermatol Venereol. 2012 Aug;26 PubMed
  7. Kajita N, Kanamori K, Yamamoto S, Yoshida K. Generalized Urticaria Caused by a Glycerin Enema in an Infant. J Investig Allergol Clin Immunol 2022;32(4):318-319. PubMed
  8. Suzuki R, Fukuyama K, Miyazaki Y, Namiki T. Contact urticaria syndrome and protein contact dermatitis caused by glycerin enema. JAAD Case Reports. 2016;2:108-10. PubMed

See these in context on the Glycerol monograph →

Sage 27 references
  1. Brinker F. Herb Contraindications and Drug Interactions. 2nd ed. Sandy, OR: Eclectic Medical Publications, 1998.
  2. Todorov S, Philianos S, Petkov V, et al. Experimental pharmacological study of three species from genus Salvia. Acta Physiol Pharmacol (Bulg) 1984;10:13-20.
  3. Perry NS, Bollen C, Perry EK, Ballard C. Salvia for dementia therapy: review of pharmacological activity and pilot tolerability clinical trial. Pharmacol Biochem Behav 2003;75:651-9.. PubMed
  4. Saller R, Buechi S, Meyrat R, Schmidhauser C. Combined herbal preparation for topical treatment of Herpes labialis. Forsch Komplementarmed Klass Naturheilkd 2001;8:373-82. PubMed
  5. Akhondzadeh S, Noroozian M, Mohammadi M, et al. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial. J Clin Pharm Ther 2003;28:53-9.
  6. Perry NB, Anderson RE, Brennan NJ, et al. Essential oils from dalmatian sage (Salvia officinalis l.): variations among individuals, plant parts, seasons, and sites. J Agric Food Chem 1999;47:2048-54..
  7. Foster BC, Vandenhoek S, Hana J, et al. In vitro inhibition of human cytochrome P450-mediated metabolism of marker substrates by natural products. Phytomedicine 2003;10:334-42.. PubMed
  8. Burkhard PR, Burkhardt K, Haenggeli CA, Landis T. Plant-induced seizures: reappearance of an old problem. J Neurol 1999;246:667-70. PubMed
  9. Bommer S, Klein P, Suter A. First time proof of sage's tolerability and efficacy in menopausal women with hot flushes. Adv Ther 2011;28:490-500. PubMed
  10. Hellum BH, Nilsen OG. The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic Clin Pharmacol Toxicol. 2007 Nov;101:350-8.
  11. Orhan, I., Kartal, M., Kan, Y., and Sener, B. Activity of essential oils and individual components against acetyl- and butyrylcholinesterase. Z.Naturforsch.C. 2008;63(7-8):547-553.
  12. Perry, N. S., Houghton, P. J., Theobald, A., Jenner, P., and Perry, E. K. In-vitro inhibition of human erythrocyte acetylcholinesterase by salvia lavandulaefolia essential oil and constituent terpenes. J Pharm Pharmacol 2000;52(7):895-902.
  13. Perry, N. S., Houghton, P. J., Sampson, J., Theobald, A. E., Hart, S., Lis-Balchin, M., Hoult, J. R., Evans, P., Jenner, P., Milligan, S., and Perry, E. K. In-vitro activity of S. lavandulaefolia (Spanish sage) relevant to treatment of Alzheimer's diseas
  14. Futrell, J. M. and Rietschel, R. L. Spice allergy evaluated by results of patch tests. Cutis 1993;52(5):288-290.
  15. Kavvadias, D., Monschein, V., Sand, P., Riederer, P., and Schreier, P. Constituents of sage (Salvia officinalis) with in vitro affinity to human brain benzodiazepine receptor. Planta Med. 2003;69(2):113-117.
  16. Savelev, S. U., Okello, E. J., and Perry, E. K. Butyryl- and acetyl-cholinesterase inhibitory activities in essential oils of Salvia species and their constituents. Phytother Res 2004;18(4):315-324.
  17. Kennedy, D. O., Pace, S., Haskell, C., Okello, E. J., Milne, A., and Scholey, A. B. Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology 2006;31(4):84 PubMed
  18. Hubbert, M., Sievers, H., Lehnfeld, R., and Kehrl, W. Efficacy and tolerability of a spray with Salvia officinalis in the treatment of acute pharyngitis - a randomised, double-blind, placebo-controlled study with adaptive design and interim analysis. Eur
  19. Lima, C. F., Fernandes-Ferreira, M., and Pereira-Wilson, C. Drinking of Salvia officinalis tea increases CCl(4)-induced hepatotoxicity in mice. Food Chem.Toxicol. 2007;45(3):456-464.
  20. Hellum, B. H. and Nilsen, O. G. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin Pharmacol Toxicol. 2008;102(5):466-475.
  21. Mayer, E., Gescheidt-Shoshany, H., and Weltfriend, S. Allergic contact dermatitis caused by Salvia officinalis extract. Contact Dermatitis 2011;64(4):237-238. PubMed
  22. Halicioglu, O., Astarcioglu, G., Yaprak, I., and Aydinlioglu, H. Toxicity of Salvia officinalis in a newborn and a child: an alarming report. Pediatr.Neurol. 2011;45(4):259-260. PubMed
  23. Sertoli, A., Fabbri, P., Campolmi, P., and Panconesi, E. Allergic contact dermatitis to Salvia Officinalis, Inula Viscosa and Conyza Bonariensis. Contact Dermatitis 1978;4(5):314-315.
  24. Vandecasteele K, Ost P, Oosterlinck W, et al. Evaluation of the efficacy and safety of Salvia officinalis in controlling hot flashes in prostate cancer patients treated with androgen deprivation. Phytother Res. 2012;26(2):208-13.
  25. Kianbakht S, Dabaghian FH. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial. Complement Ther Med. 2013;21(5):441-6. PubMed
  26. Amini L, Mojab F, Jahanfar S, Sepidarkish M, Raoofi Z, Maleki-Hajiagha A. Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical tr
  27. Behradmanesh S, Derees F, Rafieian-Kopaei M. Effect of Salvia officinalis on diabetic patients. J Renal Inj Prev. 2013;2(2):51-4.

See these in context on the Sage monograph →

Quebracho Blanco 1 reference
  1. Gruenwald J, Brendler T, Jaenicke C. PDR for Herbal Medicines. 1st ed. Montvale, NJ: Medical Economics Company, Inc., 1998.

See these in context on the Quebracho Blanco monograph →

Aristolochia 27 references
  1. van Ypersele de Strihou C, Vanherweghem JL. The tragic paradigm of Chinese herbs nephropathy. Nephrol Dial Transplant 1995;10:157-60. DOI
  2. Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-92.
  3. Lewis CJ, Alpert S. Letter to health care professionals -- FDA concerned about botanical products, including dietary supplements, containing aristolochic acid. Office of Nutritional Products, Labeling, Dietary Supplements. Center for Food Safety and Appli
  4. Arlt VM, Stiborova M, Schmeiser HH. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review. Mutagenesis 2002;17:265-77. PubMed
  5. Cronin AJ, Maidment G, Cook T, et al Aristolochic acid as a causative factor in a case of Chinese herbal nephropathy. Nephrol Dial Transplant 2002;17:524-5. PubMed
  6. Chang CH, Wang YM, Yang AH, Chiang SS. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 2001;21:441-8. PubMed
  7. Lord GM, Cook T, Arlt VM, et al. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001;358:1515-6. PubMed
  8. Lord GM, Tagore R, Cook T, et al. Nephropathy caused by Chinese herbs in the UK. Lancet 1999;354:481-2. PubMed
  9. Nortier JL, Vanherweghem JL. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). Toxicology 2002;181-182:577-80. PubMed
  10. Martinez M. C., Nortier J., Vereerstraeten P., Vanherweghem J. L. Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose. Nephrol.Dial.Transplant. 2002;17(3):408-12. PubMed
  11. Nortier, J. [Renal interstitial fibrosis and urotelial carcinomas after ingestion of a Chinese herb (Aristolochia fangchi)]. Nephrologie 2002;23(1):37-38.
  12. Ioset, J. R., Raoelison, G. E., and Hostettmann, K. Detection of aristolochic acid in Chinese phytomedicines and dietary supplements used as slimming regimens. Food Chem Toxicol 2003;41(1):29-36. PubMed
  13. Yu Y., Zheng F. L., Li H. [Chinese herbs-induced renal failure with Fanconi syndrome: a report of 6 cases]. Zhonghua Nei Ke.Za Zhi. 2003;42:110-12.
  14. Schaneberg, B. T. and Khan, I. A. Analysis of products suspected of containing Aristolochia or Asarum species. J.Ethnopharmacol. 2004;94(2-3):245-249. PubMed
  15. Chan, T. Y., Tam, H. P., Lai, C. K., and Chan, A. Y. A multidisciplinary approach to the toxicologic problems associated with the use of herbal medicines. Ther Drug Monit. 2005;27(1):53-57. PubMed
  16. Lo, S. H., Wong, K. S., Arlt, V. M., Phillips, D. H., Lai, C. K., Poon, W. T., Chan, C. K., Mo, K. L., Chan, K. W., and Chan, A. Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy. Am.J Kidney Dis. 2005;45(2):407-410. PubMed
  17. Hranjec, T., Kovac, A., Kos, J., Mao, W., Chen, J. J., Grollman, A. P., and Jelakovic, B. Endemic nephropathy: the case for chronic poisoning by aristolochia. Croat.Med J 2005;46(1):116-125.
  18. Laing, C., Hamour, S., Sheaff, M., Miller, R., and Woolfson, R. Chinese herbal uropathy and nephropathy. Lancet 7-22-2006;368(9532):338. PubMed
  19. Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., Jakovina, K., Brdar, B., Slade, N., Turesky, R. J., Goodenough, A. K., Rieger, R., Vukelic, M., and Jelakovic, B. Aristoloc
  20. Violon, C. Belgian (Chinese herb) nephropathy: why? J Pharm Belg. 1997;52(1):7-27.
  21. Liebman, B. Herbs and cancer. Nutrition Action Health Letter 2000;27(7):11-13.
  22. Ashraf, H. Chinese herbal remedy linked to kidney failure. Lancet 8-7-1999;354(9177):494. DOI
  23. Aristolochia and renal failure. WHO Drug Information 1999;13(3):174.
  24. News Potpourri. Southern Medical Journal 2000;93(11):1129-1130.
  25. Centre for Reviews and Dissemination (CRD). Systematic review: hepatotoxic events associated with herbal medicinal products. 2004;
  26. Shaohua Z, Ananda S, Ruxia Y, Liang R, Xiaorui C, Liang L. Fatal renal failure due to the Chinese herb "GuanMu Tong" (Aristolochia manshuriensis): autopsy findings and review of literature. Forensic Sci Int. 2010;199(1-3):e5-7. PubMed
  27. Tazi I, Nafil H, Mahmal L. Fatal renal failure due to self administration of Aristolochia Longa after treatment with chemotherapy. Arab J Nephrol Transplant. 2012 Jan;5(1):54; discussion 55.

See these in context on the Aristolochia monograph →

Parts of this content are provided by the Therapeutic Research Center, LLC.

DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.

© 2021 Therapeutic Research Center, LLC

Keep exploring
Supplement interaction checker › Check any supplement or product against your medications Drug–drug interactions › Check two or more of your medications against each other Browse medications A–Z › Every drug we've checked against herbs & supplements NDC & pricing lookup › Find a drug’s NDCs, packaging and costs Ask a pharmacist › Free, personal answer from our licensed team